Novel hypoglycemic injury mechanism: N-methyl-D-aspartate receptor-mediated white matter damage

Annals of Neurology

Volumn 75, Issue 4, 2014, Pages 492-507

  Yang, Xin ^a   Hamner, Margaret A ^b   Brown, Angus M ^c   Evans, Richard D ^c   Ye, Zu Cheng ^b   Chen, Shengdi ^a   Ransom, Bruce R ^b  

^a SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

6 NITRO 7 SULFAMOYLBENZO[F]QUINOXALINE 2,3 DIONE; ASPARTIC ACID; DIZOCILPINE; GLUCOSE; GLUTAMIC ACID; GLYCINE; LACTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

AGLYCEMIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CEREBROSPINAL FLUID; CONTROLLED STUDY; ELECTROPHYSIOLOGY; ENZYME ELECTRODE; GLUCOSE BLOOD LEVEL; GLYCOGEN ANALYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYPOGLYCEMIA; LACTATE BLOOD LEVEL; MOUSE; NONHUMAN; OPTIC NERVE; PH; PRIORITY JOURNAL; WHITE MATTER INJURY;

ALPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID; ANIMALS; ASPARTIC ACID; BRAIN; CALCIUM; DISEASE MODELS, ANIMAL; EXCITATORY AMINO ACID AGONISTS; EXCITATORY AMINO ACID ANTAGONISTS; GLUTAMIC ACID; GLYCINE; GLYCOGEN; HYDROGEN-ION CONCENTRATION; HYPOGLYCEMIA; KYNURENIC ACID; LACTIC ACID; LEUKOENCEPHALOPATHIES; MICE; MICE, INBRED C57BL; OPTIC NERVE INJURIES; QUINOXALINES; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 84899942512     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.24050     Document Type: Article

References (55)

1. Agardh CD, Rosen I,. Neurophysiological recovery after hypoglycemic coma in the rat: correlation with cerebral metabolism. J Cereb Blood Flow Metab 1983; 3: 78-85.
2. Arky RA,. Hypoglycemia associated with liver disease and ethanol. Endocrinol Metab Clin North Am 1989; 18: 75-90.
3. Davis EA, Jones TW,. Hypoglycemia in children with diabetes: incidence, counterregulation and cognitive dysfunction. J Pediatr Endocrinol Metab 1998; 11 (suppl 1): 177-182.
4. Lincoln NB, Faleiro RM, Kelly C, et al. Effect of long-term glycemic control on cognitive function. Diabetes Care 1996; 19: 656-658.
5. Auer RN,. Hypoglycemic brain damage. Metab Brain Dis 2004; 19: 169-175.
6. Brown AM, Wender R, Ransom BR,. Ionic mechanisms of aglycemic axon injury in mammalian central white matter. J Cereb Blood Flow Metab 2001; 21: 385-395.
7. Warren RE, Frier BM,. Hypoglycaemia and cognitive function. Diabetes Obes Metab 2005; 7: 493-503.
8. McCrimmon RJ, Ryan CM, Frier BM,. Diabetes and cognitive dysfunction. Lancet 2012; 379: 2291-2299.
9. Won SJ, Yoo BH, Kauppinen TM, et al. Recurrent/moderate hypoglycemia induces hippocampal dendritic injury, microglial activation, and cognitive impairment in diabetic rats. J Neuroinflammation 2012; 9: 182.
10. Ma JH, Kim YJ, Yoo WJ, et al. MR imaging of hypoglycemic encephalopathy: lesion distribution and prognosis prediction by diffusion-weighted imaging. Neuroradiology 2009; 51: 641-649.
11. Johkura K, Nakae Y, Kudo Y, et al. Early diffusion MR imaging findings and short-term outcome in comatose patients with hypoglycemia. AJNR Am J Neuroradiol 2012; 33: 904-909.
12. Ransom BR, Baltan SB,. Axons get excited to death. Ann Neurol 2009; 65: 120-121.
13. Matute C, Domercq M, Perez-Samartin A, Ransom BR,. Protecting white matter from stroke injury. Stroke 2013; 44: 1204-1211.
14. Stys PK, Ransom BR, Waxman SG,. Compound action potential of nerve recorded by suction electrode: a theoretical and experimental analysis. Brain Res 1991; 546: 18-32.
15. Li S, Stys PK,. Mechanisms of ionotropic glutamate receptor-mediated excitotoxicity in isolated spinal cord white matter. J Neurosci 2000; 20: 1190-1198.
16. Peng W, Cotrina ML, Han X, et al. Systemic administration of an antagonist of the ATP-sensitive receptor P2X7 improves recovery after spinal cord injury. Proc Natl Acad Sci U S A 2009; 106: 12489-12493.
17. Fern R, Moller T,. Rapid ischemic cell death in immature oligodendrocytes: a fatal glutamate release feedback loop. J Neurosci 2000; 20: 34-42.
18. Choi DW,. Excitotoxic cell death. J Neurobiol 1992; 23: 1261-1276.
19. Baltan S, Besancon EF, Mbow B, et al. White matter vulnerability to ischemic injury increases with age because of enhanced excitotoxicity. J Neurosci 2008; 28: 1479-1489.
20. McDonald JW, Althomsons SP, Hyrc KL, et al. Oligodendrocytes from forebrain are highly vulnerable to AMPA/kainate receptor-mediated excitotoxicity. Nat Med 1998; 4: 291-297.
21. Sanchez-Gomez MV, Matute C,. AMPA and kainate receptors each mediate excitotoxicity in oligodendroglial cultures. Neurobiol Dis 1999; 6: 475-485.
22. Alberdi E, Sanchez-Gomez MV, Marino A, Matute C,. Ca(2+) influx through AMPA or kainate receptors alone is sufficient to initiate excitotoxicity in cultured oligodendrocytes. Neurobiol Dis 2002; 9: 234-243.
23. Tekkok SB, Goldberg MP,. AMPA/kainate receptor activation mediates hypoxic oligodendrocyte death and axonal injury in cerebral white matter. J Neurosci 2001; 21: 4237-4248.
24. Bakiri Y, Hamilton NB, Karadottir R, Attwell D,. Testing NMDA receptor block as a therapeutic strategy for reducing ischaemic damage to CNS white matter. Glia 2008; 56: 233-240.
25. Micu I, Jiang Q, Coderre E, et al. NMDA receptors mediate calcium accumulation in myelin during chemical ischaemia. Nature 2006; 439: 988-992.
26. Li S, Mealing GA, Morley P, Stys PK,. Novel injury mechanism in anoxia and trauma of spinal cord white matter: glutamate release via reverse Na(+)-dependent glutamate transport. J Neurosci 1999; 19: RC16.
27. Hamner MA, Moller T, Ransom BR,. Anaerobic function of CNS white matter declines with age. J Cereb Blood Flow Metab 2011; 31: 996-1002.
28. Philbin DM, Ransom BR,. Anoxia-induced extracellular ion shifts in mammalian CNS white matter. In:, Federoof S, Juurlink BHJ, Doucette R, eds. Biology and pathology of astrocyte-neuron interactions. Altschul Symposia Series vol 2. New York, NY: Plenum Press, 1994: 27-50.
29. Borrelli MJ, Carlini WG, Dewey WC, Ransom BR,. A simple method for making ion-selective microelectrodes suitable for intracellular recording in vertebrate cells. J Neurosci Methods 1985; 15: 141-154.
30. Tekkok SB, Ye Z, Ransom BR,. Excitotoxic mechanisms of ischemic injury in myelinated white matter. J Cereb Blood Flow Metab 2007; 27: 1540-1552.
31. Ye ZC, Ransom BR, Sontheimer H,. (1R,3S)-1-Aminocyclopentane-1,3- dicarboxylic acid (RS-ACPD) reduces intracellular glutamate levels in astrocytes. J Neurochem 2001; 79: 756-766.
32. Wender R, Brown AM, Fern R, et al. Astrocytic glycogen influences axon function and survival during glucose deprivation in central white matter. J Neurosci 2000; 20: 6804-6810.
33. Brown AM, Tekkok SB, Ransom BR,. Glycogen regulation and functional role in mouse white matter. J Physiol 2003; 549 (pt 2): 501-512.
34. Underhill SM, Goldberg MP,. Hypoxic injury of isolated axons is independent of ionotropic glutamate receptors. Neurobiol Dis 2007; 25: 284-290.
35. Salter MG, Fern R,. NMDA receptors are expressed in developing oligodendrocyte processes and mediate injury. Nature 2005; 438: 1167-1171.
36. Mathiesen C, Varming T, Jensen LH,. In vivo and in vitro evaluation of AMPA receptor antagonists in rat hippocampal neurones and cultured mouse cortical neurones. Eur J Pharmacol 1998; 353: 159-167.
37. Traynelis SF, Wollmuth LP, McBain CJ, et al. Glutamate receptor ion channels: structure, regulation, and function. Pharmacol Rev 2010; 62: 405-496.
38. Brown AM, Evans RD, Black J, Ransom BR,. Schwann cell glycogen selectively supports myelinated axon function. Ann Neurol 2012; 72: 406-418.
39. Lee J, Taira T, Pihlaja P, et al. Effects of CO2 on excitatory transmission apparently caused by changes in intracellular pH in the rat hippocampal slice. Brain Res 1996; 706: 210-216.
40. Traynelis SF, Cull-Candy SG,. Proton inhibition of N-methyl-D-aspartate receptors in cerebellar neurons. Nature 1990; 345: 347-350.
41. McCrimmon RJ, Frier BM,. Hypoglycaemia, the most feared complication of insulin therapy. Diabete Metab 1994; 20: 503-512.
42. Zhang K, Sejnowski TJ,. A universal scaling law between gray matter and white matter of cerebral cortex. Proc Natl Acad Sci U S A 2000; 97: 5621-5626.
43. Ransom BR, Goldberg MP, Baltan SB,. Molecular pathophysiology of white matter anoxic-ischemic injury. In:, Mohr JP, ed. Stroke: pathophysiology, diagnosis and management. 5th ed. Philadelphia, PA: Elsevier/Saunders, 2011: 122-137.
44. Hansen AJ,. Effect of anoxia on ion distribution in the brain. Physiol Rev 1985; 65: 101-148.
45. Sandberg M, Butcher SP, Hagberg H,. Extracellular overflow of neuroactive amino acids during severe insulin-induced hypoglycemia: in vivo dialysis of the rat hippocampus. J Neurochem 1986; 47: 178-184.
46. Brown AM, Wender R, Ransom BR,. Metabolic substrates other than glucose support axon function in central white matter. J Neurosci Res 2001; 66: 839-843.
47. Agardh CD, Folbergrova J, Siesjo BK,. Cerebral metabolic changes in profound, insulin-induced hypoglycemia, and in the recovery period following glucose administration. J Neurochem 1978; 31: 1135-1142.
48. Pelligrino D, Siesjo BK,. Regulation of extra- and intracellular pH in the brain in severe hypoglycemia. J Cereb Blood Flow Metab 1981; 1: 85-96.
49. Rothman SM, Olney JW,. Glutamate and the pathophysiology of hypoxic-ischemic brain damage. Ann Neurol 1986; 19: 105-111.
50. Stys PK, Waxman SG, Ransom BR,. Na(+)-Ca2+ exchanger mediates Ca2+ influx during anoxia in mammalian central nervous system white matter. Ann Neurol 1991; 30: 375-380.
51. Pina-Crespo JC, Talantova M, Micu I, et al. Excitatory glycine responses of CNS myelin mediated by NR1/NR3 "NMDA" receptor subunits. J Neurosci 2010; 30: 11501-11505.
52. Madry C, Mesic I, Bartholomaus I, et al. Principal role of NR3 subunits in NR1/NR3 excitatory glycine receptor function. Biochem Biophys Res Commun 2007; 354: 102-108.
53. LoPachin RM Jr, Stys PK,. Elemental composition and water content of rat optic nerve myelinated axons and glial cells: effects of in vitro anoxia and reoxygenation. J Neurosci 1995; 15: 6735-6746.
54. Suh SW, Hamby AM, Swanson RA,. Hypoglycemia, brain energetics, and hypoglycemic neuronal death. Glia 2007; 55: 1280-1286.
55. Nellgard B, Wieloch T,. Cerebral protection by AMPA- and NMDA-receptor antagonists administered after severe insulin-induced hypoglycemia. Exp Brain Res 1992; 92: 259-266.